SC

(redirected from subcutaneous)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to subcutaneous: subcutaneous edema

SC

The two-character ISO 3166 country code for SEYCHELLES.

SC

1. ISO 3166-1 alpha-2 code for the Republic of the Seychelles. This is the code used in international transactions to and from Seychellois bank accounts.

2. ISO 3166-2 geocode for the Seychelles. This is used as an international standard for shipping to the Seychelles. Each district has its own code with the prefix "SC." For example, the code for the District of Bel Air is ISO 3166-2:SC-09.
References in periodicals archive ?
The subcutaneous formulation is administered once a week via subcutaneous injection, which enables a high bioavailability to be maintained.
Table-I: Comparison of incidence of subcutaneous bleeding between the two groups [n(%)].
For the tip defects, two-stage interpolation type nasolabial flaps and subcutaneous pedicled nasolabial flaps were used.
Our study showed a significant positive correlation between visceral fat and subcutaneous fat with fasting blood sugar in the middle-aged male offspring of diabetic parents similar to a study conducted by Shahid et al.
The purpose of this study was to compare pain and bruising associated with subcutaneous injection of the LMWH enoxaparin at two sites: abdomen and arm.
Computed tomography of the chest, abdomen, and pelvis revealed a left-sided pneumothorax and subcutaneous emphysema (Figures 2(a) and 2(b)).
The diagnosis of IDA is made based on clinical evidence of a palpable subcutaneous mass and histopathological evidence of amyloid deposition [8].
In the present study, subcutaneous LCH was documented in a child with a history of trauma to the nose.
The nodules were firm, well-circumscribed, nonsuppurative, mobile subcutaneous masses, and their diameters ranged from 1-2 cm to 2-3 cm.
These studies also have used oral formulations of methotrexate, in a range of starting doses as low as 5 mg, rather than subcutaneous formulations.
GSK said the approval marks the first subcutaneous self-injection treatment option for patients with SLE, which is the most common form of lupus, a chronic, incurable autoimmune disease producing autoantibodies that can attack almost any system in the body.